Stockadora

8-K filings / November 20, 2026

NextCure, Inc.: A stock exchange listing notice

NextCure, Inc. filed a current report (Form 8-K) with the SEC on November 20, 2026. It reports a stock exchange listing notice.

AI-written from the facts below

In plain English

On November 16, 2026, the company received a notice from Nasdaq concerning its stock exchange listing. According to the notice, Nasdaq states that the company does not meet Listing Rule 5450(b)(1)(A).

What each sentence states
“On November 16, 2026, the company received a notice from Nasdaq concerning its stock exchange listing.”
  • Item 3.01 of Form 8-K covers notices about a company's stock exchange listing.
  • Item 3.01: the exchange is Nasdaq.
  • Item 3.01: the company received the exchange's notice on November 16, 2026.
“According to the notice, Nasdaq states that the company does not meet Listing Rule 5450(b)(1)(A).”
  • Item 3.01: the exchange is Nasdaq.
  • Item 3.01: what it reports: the exchange says the company does not meet a listing rule.
  • Item 3.01: the rule cited is Listing Rule 5450(b)(1)(A).
Written by an AI model from the facts on this page only; code and a second model checked every sentence against them.

Item 3.01

Stock exchange listing notice

  • Exchange Nasdaq From the filing
    Source
    “On November 16, 2026, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that we were not in compliance with the minimum stockholders’ equity requirement applicable to companies listed on the Nasdaq Global Select Market under Listing Rule 5450(b)(1)(A) (the “Minimum Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $5,503,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, was below the required minimum of $10.0 million, and because, as of November 16, 2026, the Company did not meet the alternative compliance standards relating to the market value of the listed securities or the Company’s total assets and revenue.”
    Read by code from this sentence of the filing.
  • What it says The company does not meet a listing rule From the filing
    Source
    “On November 16, 2026, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that we were not in compliance with the minimum stockholders’ equity requirement applicable to companies listed on the Nasdaq Global Select Market under Listing Rule 5450(b)(1)(A) (the “Minimum Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $5,503,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, was below the required minimum of $10.0 million, and because, as of November 16, 2026, the Company did not meet the alternative compliance standards relating to the market value of the listed securities or the Company’s total assets and revenue.”
    Read by code from this sentence of the filing.
  • Rule cited Listing Rule 5450(b)(1)(A) From the filing
    Source
    “On November 16, 2026, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that we were not in compliance with the minimum stockholders’ equity requirement applicable to companies listed on the Nasdaq Global Select Market under Listing Rule 5450(b)(1)(A) (the “Minimum Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $5,503,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, was below the required minimum of $10.0 million, and because, as of November 16, 2026, the Company did not meet the alternative compliance standards relating to the market value of the listed securities or the Company’s total assets and revenue.”
    Read by code from this sentence of the filing.
  • Notice date November 16, 2026 From the filing
    Source
    “On November 16, 2026, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that we were not in compliance with the minimum stockholders’ equity requirement applicable to companies listed on the Nasdaq Global Select Market under Listing Rule 5450(b)(1)(A) (the “Minimum Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $5,503,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, was below the required minimum of $10.0 million, and because, as of November 16, 2026, the Company did not meet the alternative compliance standards relating to the market value of the listed securities or the Company’s total assets and revenue.”
    Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov

Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.